Lv11
60 积分 2024-09-19 加入
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)01811-2/abstract
4小时前
已完结
Savolitinib plus osimertinib versus chemotherapy for advanced, EGFR mutation-positive, MET-amplified non-small-cell lung cancer in China (SACHI): interim analysis of a multicentre, open-label, phase 3 randomised controlled trial
6小时前
已完结
皖公网安备34019202002308
